Mara Goldstein
Stock Analyst at Clear Street
(0.14)
# 4,594
Out of 4,690 analysts
1000
Total ratings
34.5%
Success rate
-4.7%
Average return
Main Sectors:
Stocks Rated by Mara Goldstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Maintained: Buy | $45 → $32 | $9.66 | +231.26% | 4 | Aug 25, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $26 | $5.04 | +415.87% | 1 | Aug 3, 2026 | |
| KURA Kura Oncology | Maintained: Buy | $32 → $30 | $12.66 | n/a | 5 | Aug 18, 2025 | |
| INCY Incyte | Maintained: Hold | $77 → $74 | $124.37 | n/a | 73 | Aug 4, 2025 | |
| IOVA Iovance Biotherapeutics | Maintained: Buy | $30 | $8.01 | n/a | 50 | Feb 8, 2024 | |
| MRK Merck & Co. | Reiterated: Buy | $138 | $148.35 | n/a | 121 | Feb 5, 2024 | |
| ADAPY Adaptimmune Therapeutics plc | Reiterated: Buy | $9 | $0.028 | n/a | 47 | Jan 31, 2024 | |
| RCUS Arcus Biosciences | Reiterated: Buy | $51 → $42 | $29.21 | n/a | 79 | Jan 29, 2024 | |
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $45 | $19.54 | n/a | 3 | Jan 24, 2024 | |
| CYPH Cypherpunk Technologies | Maintained: Buy | $12 | $1.71 | n/a | 31 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.34 | n/a | 54 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $59 → $50 | $26.06 | n/a | 55 | Jan 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175 → $7 | $0.0003 | n/a | 23 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $7.22 | n/a | 44 | Jan 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $18.03 | n/a | 12 | Jan 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.43 | n/a | 49 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $3.21 | n/a | 51 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.04 | n/a | 33 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.99 | n/a | 8 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3.5 | $14.16 | n/a | 49 | Dec 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $5 | $72.52 | n/a | 25 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.58 | n/a | 26 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.8786 | n/a | 7 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1288 | n/a | 2 | Feb 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $140.25 | n/a | 5 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $33.87 | n/a | 2 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $8.56 | n/a | 1 | Jun 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 → $14 | $72.09 | n/a | 17 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $2.90 | n/a | 27 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $25 | $1.87 | n/a | 14 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.000001 | n/a | 3 | Apr 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $135 → $45 | $39.12 | n/a | 24 | Apr 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $3.81 | n/a | 18 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12.17 | $0.83 | n/a | 1 | Dec 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 | $199.02 | n/a | 1 | Dec 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $277 | $218.50 | n/a | 1 | Apr 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $15.19 | n/a | 8 | Apr 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $14 | $1.22 | n/a | 4 | Apr 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $0.6449 | n/a | 1 | Apr 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.60 | n/a | 2 | Oct 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.001 | n/a | 9 | Apr 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $2 | $13.21 | n/a | 8 | Dec 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $0.0001 | n/a | 2 | Jan 24, 2014 |
REGENXBIO
Aug 25, 2026
Maintained: Buy
Price Target: $45 → $32
Current: $9.66
Upside: +231.26%
Wave Life Sciences
Aug 3, 2026
Maintained: Buy
Price Target: $26
Current: $5.04
Upside: +415.87%
Kura Oncology
Aug 18, 2025
Maintained: Buy
Price Target: $32 → $30
Current: $12.66
Upside: n/a
Incyte
Aug 4, 2025
Maintained: Hold
Price Target: $77 → $74
Current: $124.37
Upside: n/a
Iovance Biotherapeutics
Feb 8, 2024
Maintained: Buy
Price Target: $30
Current: $8.01
Upside: n/a
Merck & Co.
Feb 5, 2024
Reiterated: Buy
Price Target: $138
Current: $148.35
Upside: n/a
Adaptimmune Therapeutics plc
Jan 31, 2024
Reiterated: Buy
Price Target: $9
Current: $0.028
Upside: n/a
Arcus Biosciences
Jan 29, 2024
Reiterated: Buy
Price Target: $51 → $42
Current: $29.21
Upside: n/a
Syndax Pharmaceuticals
Jan 24, 2024
Reiterated: Buy
Price Target: $45
Current: $19.54
Upside: n/a
Cypherpunk Technologies
Jan 23, 2024
Maintained: Buy
Price Target: $12
Current: $1.71
Upside: n/a
Jan 22, 2024
Reiterated: Buy
Price Target: $12
Current: $2.34
Upside: n/a
Jan 21, 2024
Rated: Buy
Price Target: $59 → $50
Current: $26.06
Upside: n/a
Jan 16, 2024
Maintained: Buy
Price Target: $175 → $7
Current: $0.0003
Upside: n/a
Jan 15, 2024
Maintained: Buy
Price Target: $36
Current: $7.22
Upside: n/a
Jan 15, 2024
Maintained: Buy
Price Target: $7
Current: $18.03
Upside: n/a
Jan 12, 2024
Maintained: Buy
Price Target: $8
Current: $2.43
Upside: n/a
Jan 5, 2024
Maintained: Hold
Price Target: $2
Current: $3.21
Upside: n/a
Jan 4, 2024
Maintained: Buy
Price Target: $8
Current: $1.04
Upside: n/a
Dec 12, 2023
Maintained: Buy
Price Target: $20
Current: $4.99
Upside: n/a
Dec 10, 2023
Rated: Hold
Price Target: $3.5
Current: $14.16
Upside: n/a
Nov 8, 2023
Rated: Hold
Price Target: $6 → $5
Current: $72.52
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: n/a
Current: $36.58
Upside: n/a
May 16, 2022
Maintained: Hold
Price Target: $2
Current: $0.8786
Upside: n/a
Feb 18, 2022
Rated: Hold
Price Target: n/a
Current: $0.1288
Upside: n/a
Oct 1, 2021
Reiterated: Buy
Price Target: n/a
Current: $140.25
Upside: n/a
Jun 8, 2021
Maintained: Buy
Price Target: n/a
Current: $33.87
Upside: n/a
Jun 22, 2020
Reiterated: Buy
Price Target: $24
Current: $8.56
Upside: n/a
Sep 20, 2018
Initiated Coverage: Buy
Price Target: $10 → $14
Current: $72.09
Upside: n/a
Jun 13, 2018
Maintained: Hold
Price Target: $6
Current: $2.90
Upside: n/a
May 1, 2018
Reiterated: Buy
Price Target: $18 → $25
Current: $1.87
Upside: n/a
Apr 18, 2018
Maintained: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Apr 16, 2018
Downgraded: Hold
Price Target: $135 → $45
Current: $39.12
Upside: n/a
Mar 19, 2018
Maintained: Buy
Price Target: $12
Current: $3.81
Upside: n/a
Dec 29, 2017
Reiterated: Buy
Price Target: $12.17
Current: $0.83
Upside: n/a
Dec 1, 2017
Rated: Buy
Price Target: $13
Current: $199.02
Upside: n/a
Apr 28, 2017
Reiterated: Hold
Price Target: $277
Current: $218.50
Upside: n/a
Apr 13, 2017
Reiterated: Hold
Price Target: $7
Current: $15.19
Upside: n/a
Apr 13, 2017
Reiterated: Hold
Price Target: $2 → $14
Current: $1.22
Upside: n/a
Apr 13, 2017
Reiterated: Buy
Price Target: $15
Current: $0.6449
Upside: n/a
Oct 7, 2016
Reiterated: Buy
Price Target: $7
Current: $1.60
Upside: n/a
Apr 7, 2016
Reiterated: Buy
Price Target: n/a
Current: $0.001
Upside: n/a
Dec 8, 2015
Upgraded: Hold
Price Target: $2
Current: $13.21
Upside: n/a
Jan 24, 2014
Downgraded: Hold
Price Target: $4 → $2
Current: $0.0001
Upside: n/a